D.A. DAVIDSON & CO. - IMMUNOGEN INC ownership

IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 199 filers reported holding IMMUNOGEN INC in Q2 2018. The put-call ratio across all filers is 0.80 and the average weighting 0.0%.

Quarter-by-quarter ownership
D.A. DAVIDSON & CO. ownership history of IMMUNOGEN INC
ValueSharesWeighting
Q1 2019$215,000
-43.9%
79,406
-0.5%
0.00%
-42.9%
Q4 2018$383,000
-51.0%
79,792
-3.2%
0.01%
-50.0%
Q3 2018$781,000
-6.9%
82,441
-4.4%
0.01%
-12.5%
Q2 2018$839,000
-10.8%
86,233
-3.6%
0.02%
-15.8%
Q1 2018$941,000
+57.4%
89,430
-4.2%
0.02%
+46.2%
Q4 2017$598,000
-17.3%
93,349
-1.3%
0.01%
-7.1%
Q3 2017$723,000
+7.9%
94,565
+0.2%
0.01%
-6.7%
Q2 2017$670,000
+63.8%
94,351
-10.7%
0.02%
+50.0%
Q1 2017$409,000
+92.0%
105,690
+0.6%
0.01%
+100.0%
Q4 2016$213,000
-25.3%
105,068
-1.8%
0.01%
-28.6%
Q3 2016$285,000
+21.3%
106,974
+39.7%
0.01%0.0%
Q2 2016$235,000
-62.5%
76,559
+3.9%
0.01%
-65.0%
Q1 2016$627,000
-36.3%
73,675
+1.4%
0.02%
-37.5%
Q4 2015$985,000
+41.3%
72,671
-0.0%
0.03%
+33.3%
Q3 2015$697,000
-32.7%
72,685
+0.8%
0.02%
-29.4%
Q2 2015$1,036,000
+24.4%
72,112
-22.6%
0.03%
+25.9%
Q1 2015$833,000
+82.7%
93,147
+24.2%
0.03%
+80.0%
Q4 2014$456,000
-28.1%
74,970
+25.1%
0.02%
-28.6%
Q3 2014$634,000
+4.3%
59,933
+16.3%
0.02%0.0%
Q2 2014$608,000
+14.1%
51,514
+43.6%
0.02%
+10.5%
Q1 2014$533,000
+25.1%
35,865
+22.9%
0.02%
+18.8%
Q4 2013$426,000
-6.4%
29,174
+9.0%
0.02%
-20.0%
Q3 2013$455,000
+9.6%
26,769
+6.4%
0.02%0.0%
Q2 2013$415,00025,1670.02%
Other shareholders
IMMUNOGEN INC shareholders Q2 2018
NameSharesValueWeighting ↓
QVT Financial LP 1,375,900$6,329,0001.08%
Redmile Group, LLC 12,006,979$55,232,0001.02%
Birchview Capital, LP 190,000$874,0000.53%
Fernwood Investment Management, LLC 179,340$825,0000.41%
HealthCor Management, L.P. 1,200,000$5,520,0000.23%
Grace Capital 49,500$228,0000.20%
TWIN FOCUS CAPITAL PARTNERS, LLC 104,068$479,0000.19%
Virtus ETF Advisers LLC 79,795$367,0000.17%
PINNACLE ASSOCIATES LTD 1,087,034$5,000,0000.12%
HUSSMAN STRATEGIC ADVISORS, INC. 100,000$460,0000.12%
View complete list of IMMUNOGEN INC shareholders